Drugs / gadoterate dimeglumine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02431598 Comparator | Jun → Sep 2015 | — | Duke University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gadoterate dimeglumine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02431598 ↗ |
| Modality | Diagnostic / imaging agent | “gadolinium-based contrast agent administration” NCT02431598 ↗ |